A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.

A S Pappo; E Etcubanas; V M Santana; B N Rao; L E Kun; J Fontanesi; P K Roberson; L C Bowman; W M Crist; D N Shapiro

doi:10.1002/1097-0142(19930315)71:6<2119::aid-cncr2820710629>3.0.co;2-y

A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.

Identifier:nobleid.org/w1/20260515/2E7FD63F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2E7FD63F.svg?ark=w1%2F20260515%2F2E7FD63F)](https://nobleid.org/work/w1/20260515/2E7FD63F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.

Identifier:nobleid.org/w1/20260515/2E7FD63F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2E7FD63F.svg?ark=w1%2F20260515%2F2E7FD63F)](https://nobleid.org/work/w1/20260515/2E7FD63F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work